JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KIN
3901
DELISTED
Kindred Biosciences, Inc.
KIN
| $119K | ﹤0.01% |
+13,816
| New | +$99.1K |
2017 Q2
0 quarters
|
|
3902
PC Connection
CNXN
$2.36B
| $118K | ﹤0.01% |
4,344
-4,298
| -50% | -$118K |
2016 Q4
2 quarters
|
|
3903
Entravision Communication
EVC
$661M
| $117K | ﹤0.01% |
17,700
-54,802
| -76% | -$332K |
2017 Q1
1 quarter
|
|
|
SCMP
3904
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $117K | ﹤0.01% |
+11,141
| New | +$114K |
2017 Q2
0 quarters
|
|
3905
BlackRock Multi-Sector Income Trust
BIT
$637M
| $116K | ﹤0.01% |
6,413
+3,113
| +94% | +$55.4K |
2016 Q4
2 quarters
|
|
3906
Dorchester Minerals
DMLP
$1.42B
| $116K | ﹤0.01% |
8,000
-1,000
| -11% | -$16.3K |
2013 Q2
16 quarters
|
|
3907
Entegris
ENTG
$25.6B
| $116K | ﹤0.01% |
5,311
-6,099
| -53% | -$147K |
2015 Q4
6 quarters
|
|
3908
Fidelity MSCI Industrials Index ETF
FIDU
$2.22B
| $116K | ﹤0.01% |
3,330
+819
| +33% | +$28K |
2015 Q4
6 quarters
|
|
|
HEPA
3909
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
2015 Q4
6 quarters
|
|
3910
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.2B
| $115K | ﹤0.01% |
3,118
-13
| -0.4% | -$471 |
2017 Q1
1 quarter
|
|
3911
Invesco CurrencyShares British Pound Sterling Trust
FXB
$89M
| $115K | ﹤0.01% |
907
-1,210
| -57% | -$151K |
2016 Q2
4 quarters
|
|
|
STRR
3912
DELISTED
Star Equity Holdings
STRR
| $115K | ﹤0.01% |
568
-142
| -20% | -$31.2K |
2016 Q1
5 quarters
|
|
|
AMRB
3913
DELISTED
American River Bankshares
AMRB
| $115K | ﹤0.01% |
7,943
+5,443
| +218% | +$77.9K |
2017 Q1
1 quarter
|
|
|
MRCC
3914
DELISTED
Monroe Capital Corp
MRCC
| $114K | ﹤0.01% |
+7,500
| New | +$117K |
2017 Q2
0 quarters
|
|
|
CTG
3915
DELISTED
Computer Task Group, Inc.
CTG
| $114K | ﹤0.01% |
20,292
-3,535
| -15% | -$19.9K |
2015 Q4
6 quarters
|
|
3916
Main Street Capital
MAIN
$5.14B
| $113K | ﹤0.01% |
2,921
-143
| -5% | -$5.55K |
2015 Q4
6 quarters
|
|
|
LBAI
3917
DELISTED
Lakeland Bancorp Inc
LBAI
| $113K | ﹤0.01% |
6,005
-14,744
| -71% | -$284K |
2013 Q2
16 quarters
|
|
3918
Mercer International
MERC
$16.8M
| $112K | ﹤0.01% |
9,706
-9,298
| -49% | -$108K |
2016 Q1
5 quarters
|
|
|
NATI
3919
DELISTED
National Instruments Corp
NATI
| $112K | ﹤0.01% |
2,787
-2,058
| -42% | -$74.9K |
2013 Q2
16 quarters
|
|
3920
iShares MSCI USA Momentum Factor ETF
MTUM
$20.7B
| $111K | ﹤0.01% |
1,250
-476
| -28% | -$41.2K |
2015 Q1
9 quarters
|
|
|
DDC
3921
DELISTED
Dominion Diamond Corporation
DDC
| $111K | ﹤0.01% |
8,835
| – | – |
2017 Q1
1 quarter
|
|
3922
Brookfield Renewable
BEP
$8.5B
| $109K | ﹤0.01% |
+6,423
| New | +$108K |
2017 Q2
0 quarters
|
|
3923
Willdan Group
WLDN
$1.11B
| $109K | ﹤0.01% |
+3,574
| New | +$112K |
2017 Q2
0 quarters
|
|
|
SA
3924
PUT
Seabridge Gold
SA
$2.94B
| $108K | ﹤0.01% |
+10,000
| New | +$106K |
2017 Q2
0 quarters
|
|
3925
PUT
Unilever
UL
$129B
| $108K | ﹤0.01% |
1,778
-89
| -5% | -$5.31K |
2017 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.